MD, MPH, MBA, Deputy Chief Health Officer, IBM Watson Health

A trusted treatment option from Watson: Why concordance studies matter

Written by Andrew Norden, MD | Oncology & Genomics

Hearing diverse opinions from multiple oncologists is an important part of a patient’s journey, what’s often referred to as getting a second – or third – opinion. And cancer docs, too, frequently consult with one another to confirm a decision or provide a new idea. That’s understandable because cancer is a complex and sometimes elusive ...read more